The Atlanta-based company will transfer full ownership to Baxter (NYSE: BAX) + , following a sale agreement that occurred in July 2021.
Artivion anticipates receiving an $18.75 million milestone payment under the terms of the agreement. Of this, $4.5 million will go to Artivion’s former partner, Starch Medical.
As part of the terms of the agreement, Artivion will supply Baxter with PerClot for a minimum of 21 months. This term will last until all manufacturing operations are successfully transferred to Baxter or its selected designee.It’s an important milestone for Artivion
In a news release,…